FDA cancels meeting to review Lilly’s Cymbalta
The agency said the meeting was canceled “to allow time for the FDA to review new information” about a proposed new use for
the drug.
Health Care & Life Sciences
Articles
Indiana nears 1M mark in swine-flu vaccinations
So far this year, 35 people have died in Indiana from swine flu.
Grass-roots groups prepare to fill gaps in health care reform
Legislation set to come out of Washington will not change the most fundamental problems of the health
care system, leaving it up to states, cities and companies to figure out what to do about it.
Entrepreneur says quality of venture capital as important as quantity
Jim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads:
Teach entrepreneurs the value of money.
Health care software firm RealMed regains momentum
RealMed enjoys a nearly 99-percent renewal rate among its current customers and attracted 4,000 new doctors
in 2009. Employment at the company is rising after a steady decline.
St. Francis sues OrthoIndy over new surgery center
Legal complaint alleges new $20 million facility in Greenwood breaches partnership deal struck in 2001.
Corporations bet on insiders to bend reform
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
To keep sales force busy, Lilly takes on new drug
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
Lilly scurries to get out from under Zyprexa cloud
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
Health care industry braces for reform
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity
late in the year.
First decade of century marked by buyouts and bubbles
The decade witnessed a massive terrorist attack, two wars, and a building-and-buyout boom fueled by easy credit.
Conseco raises nearly $223 million in stock offering
The Carmel-based life and health insurer immediately applied $161 million of the funds to its bank loans.
Investors cheer Senate bill while WellPoint cries foul
Exemption for not-for-profit health plans could saddle WellPoint with nearly $2 billion a year in new taxes.
Lilly pays $90 million for autoimmune drug
By acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on autoimmune
diseases.
Health Care bill clears key Senate test
Landmark health care legislation backed by President Barack Obama passed its sternest Senate test in the pre-dawn hours early
Monday, overcoming Republican delaying tactics on a 60-40 vote that all but assures its passage by Christmas.
Building trades leaders flock to Wishard meetings
Hundreds of potential contractors turned out for informational meetings this week about construction work on a new Wishard Memorial Hospital.
Hoosier biz groups oppose Senate health bill
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Setbacks in diabetes market batter Roche
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And
it’s mulling whether to keep fighting on all fronts or to pull back.
Judge fines woman waging Web war against plastic surgeon
Judge Sarah Evans Barker declared a Massachusetts woman in contempt of court for failing to remove her negative Internet
postings about an Indianapolis cosmetic surgeon.
First Indiana Future Fund off to a slow start
More than half of the venture capital fund’s original investors took a pass on its $58 million successor, the newly launched
INext.